Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Synovus Financial Prices Public Offering Of 59.87 Mln Shares At $3.09/shr

RELATED NEWS
Trade SNV now with 

Synovus Financial Corp. (SNV: Quote) announced it has priced a public offering of 59.87 million shares of its common stock at $3.09 per share. The offering will generate net proceeds of about $175 million. The closing date for the transaction is expected to be July 24, 2013.

The company said it intends to use the net proceeds of this offering, the net proceeds of a planned $130 million preferred stock offering and a $680 million dividend from its subsidiary bank to redeem all of the 967,870 shares of its Fixed Rate Cumulative Perpetual Preferred Stock, Series A, issued to the United States Department of the Treasury pursuant to the Capital Purchase Program as part of its Troubled Asset Relief Program.

Click here to receive FREE breaking news email alerts for Synovus Financial and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Pro-democracy demonstrations in Hong Kong demanding greater electoral reform entered the sixth day on Wednesday, which also marks China's 65th National Day. Thousands of protesters continue to occupy parts of downtown Hong Kong vowing not to leave until they achieve their goals. They want China... Employment in the U.S. private sector increased by more than expected in the month of September, according to a report released by payroll processor ADP on Wednesday, with employment rising by more than 200,000 jobs for the sixth straight month. After ending each of the two previous sessions modestly lower, stocks may see some further downside in early trading on Wednesday. The major index futures are currently pointing to a moderately lower open for the markets, with the Dow futures down by 34 points.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.